Trending News

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025
Posted On Thursday, June 26, 2025
Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades
Posted On Thursday, June 26, 2025
Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
Posted On Thursday, June 26, 2025
Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation
Posted On Thursday, June 26, 2025
Indacloud Unveils Top Premium THCA Flower Line
Posted On Thursday, June 26, 2025
Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company
Posted On Thursday, June 26, 2025
Longeveron® Appoints Than Powell as Chief Business Officer
Posted On Thursday, June 26, 2025
Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
Posted On Thursday, June 26, 2025
Quoin Pharmaceuticals Releases New NETHERTON NOW Video Featuring Professor Jemima Mellerio, International Expert in Genetic Skin Diseases
Posted On Thursday, June 26, 2025
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer
Posted On Thursday, June 26, 2025
Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
Posted On Thursday, June 26, 2025
Arcutis’ ZORYVE® (roflumilast) Cream 0.15% Receives Strong Recommendation in American Academy of Dermatology Updated Guidelines for Adult Atopic Dermatitis
Posted On Thursday, June 26, 2025
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
Posted On Thursday, June 26, 2025
BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)
Posted On Thursday, June 26, 2025
Annovis to Attend the AAIC 2025 with Four Poster Presentations
Posted On Thursday, June 26, 2025
Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation
Posted On Thursday, June 26, 2025
aTyr Pharma to be Added to the Russell 2000® and Russell 3000® Indexes
Posted On Thursday, June 26, 2025
Pure Harvest Corporate Group Provides Corporate Update and Announces Significant Debt Reductions
Posted On Thursday, June 26, 2025
GRI Bio’s GRI-0621 Demonstrates Encouraging Safety Results at Planned Interim 6-Week Analysis in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
Posted On Thursday, June 26, 2025
Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement Financing
Posted On Thursday, June 26, 2025
HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements
Posted On Thursday, June 26, 2025
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary
Posted On Thursday, June 26, 2025
BridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ET
Posted On Thursday, June 26, 2025
Invivyd Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active Infection
Posted On Thursday, June 26, 2025
Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH
Posted On Thursday, June 26, 2025

Print